• 60 per cent public demand improvement in accessing community services, new NHS research reveals
    by rudra mulmule on May 22, 2024 at 3:47 pm

    According to the proportion of NHS spending on general practice currently at its lowest in nearly a decade A groundbreaking research project has revealed that the public is urging the government to prioritise primary and community care over hospitals. The study also found a strong public willingness to pay higher taxes to enhance NHS services. The post 60 per cent public demand improvement in accessing community services, new NHS research reveals appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Community pharmacists urged to build ‘strong relationships’ with local GPs : CPE
    by rudra mulmule on May 22, 2024 at 1:03 pm

    Strong collaboration between GPs and community pharmacists essential to pharmacy first service successful, the CPE highlight To maximise the benefits of the Pharmacy First service for patients, the NHS, and community pharmacies, Community Pharmacy England (CPE) has advised the community pharmacists to  to establish a robust relationship between community pharmacies and local general practices. The The post Community pharmacists urged to build ‘strong relationships’ with local GPs : CPE appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Pharmacy should be viewed as an equal partner on ICBs – Peers agree with CPE
    by longjam.dineshwori on May 22, 2024 at 10:48 am

    Peers supported measures such as generic medicine substitution as a short-term means to ease some issues Community Pharmacy England (CPE) highlighted the insufficient representation of pharmacists on Integrated Care Boards (ICBs) while briefing Peers about the severe challenges currently facing community pharmacies on Tuesday. Peers in attendance agreed with CPE chief executive Janet Morrison that The post Pharmacy should be viewed as an equal partner on ICBs – Peers agree with CPE appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • RPS election results 2024 announced: Check the names of elected members
    by longjam.dineshwori on May 21, 2024 at 5:26 pm

    According to RPS chief executive Paul Bennett, voter participation in England has increased by nearly 3% to 10.1% this year The Royal Pharmaceutical Society (RPS) has announced the results of the 2024 elections for its three national Pharmacy Boards. For the English Pharmacy Board, the newly elected members include Claire Anderson, Martin Astbury, Steve Churton, The post RPS election results 2024 announced: Check the names of elected members appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • NHS and government apologies to more than 30K over Infected Blood Inquiry report
    by rudra mulmule on May 21, 2024 at 11:28 am

    The infected blood inquiry report cites failures in communication and risk management in blood transfusions The final report of the Infected Blood Inquiry has been published today, bringing to light a devastating chapter in the history of the UK’s healthcare system. The inquiry, which was launched by former Prime Minister Theresa May in 2017, examined The post NHS and government apologies to more than 30K over Infected Blood Inquiry report appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • High-dispensing pharmacy sold after 50 years, Matrix Pharmacy offloads off-patch branch
    by longjam.dineshwori on May 21, 2024 at 11:24 am

    A first-time buyer has taken over Bishop Waltham Pharmacy, previously owned by Matrix Primary Healthcare Ltd. Christie & Co, a specialist business property adviser, recently finalised the sale of two pharmacies—one located in Wales and the other in Hampshire. Sylvia Williams Chemist, a well-performing community pharmacy located on the main high street of the Vale The post High-dispensing pharmacy sold after 50 years, Matrix Pharmacy offloads off-patch branch appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • #SaveOurPharmacies: NPA distributes fair funding campaign posters, stickers
    by PB Staff Writer on May 20, 2024 at 1:48 pm

    The National Pharmacy Association (NPA) is distributing new campaign materials to pharmacies across England this week to empower them to advocate for fair funding in the forthcoming general election. These include campaign posters, stickers, postcards for patients to send to MPs and petition materials. By supplying these resources, the NPA aims to boost its cross-sector The post #SaveOurPharmacies: NPA distributes fair funding campaign posters, stickers appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Lake District pharmacy grapples with medicine shortages amidst growing crisis
    by rudra mulmule on May 20, 2024 at 12:50 pm

    79% of pharmacists fear for patient health according to Community Pharmacy England report A Lake District pharmacy is grappling with significant medication supply issues, affecting its ability to provide essential drugs to customers amidst nationwide drug shortages. According to Simon Butterworth, whose family has operated Collins & Butterworth Pharmacy in Hawkshead for nearly 40 years, The post Lake District pharmacy grapples with medicine shortages amidst growing crisis appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Common antibiotic for whooping cough treatment ‘completely out of stock’ – Dr. Leyla Hannbeck
    by longjam.dineshwori on May 20, 2024 at 12:26 pm

    Whooping cough caused five infant deaths in the first quarter of 2024, according to UKHSA Pharmacists in the UK are reporting significant shortages of a common antibiotic used to treat whooping cough (pertussis), amid rising cases of this bacterial infection. Dr. Leyla Hannbeck, chief executive of the Independent Pharmacies Association (IPA), told BBC Radio 4’s The post Common antibiotic for whooping cough treatment ‘completely out of stock’ – Dr. Leyla Hannbeck appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Labour with Nuffield Health to aid thousands of NHS staff with joint pain return to work
    by rudra mulmule on May 20, 2024 at 11:01 am

    Nurses accounted for 52,000 of sick days, doctors for 3,500, both up since 2019 as per the Labour report “Record long NHS waits are forcing huge numbers of people out of work, including doctors and nurses,” said Wes Streeting MP, Labour’s Shadow Health and Social Care Secretary as Labour announced a new partnership with Nuffield The post Labour with Nuffield Health to aid thousands of NHS staff with joint pain return to work appeared first on Latest Pharmacy News | Business | Magazine - Pharmacy Business.

  • Five reasons why pharma should use a vacancy management service
    by Danny Dorward on May 20, 2024 at 8:30 am

    Vacancy management is just one of the many talent services we offer our pharma, medtech and biotech clients. Our leading solution allows you to maintain customer engagement and promotional focus when a flexible solution is required. Looking for more information? Here are five reasons why pharma companies looking for flexibility of resource should choose the

  • AlzeCure drug presents opportunity to treat Alzheimer’s disease
    by Joanna Harvey on May 16, 2024 at 9:21 am

    AlzeCure, a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer’s disease and pain, has received preclinical data for NeuroRestore in inflammation, presenting an opportunity to treat Alzheimer’s disease, which is being prepared for phase II clinical studies. The data shows that the NeuroRestore substance ACD856 exhibits anti-inflammatory properties

  • Dare to be disruptive – how to model your European go to market strategy for success 
    by Nick Bartlett on May 15, 2024 at 10:09 am

    Refreshed and re-energised after returning from Reuters Pharma 2024 in Barcelona, Nick Bartlett, Head of Consulting at Uniphar, brings you key takeaways from the workshop he led about shaking up disruption in pharma, European go to market models and embracing change.   The Uniphar team joined over 1200 industry leaders to discuss innovation in healthcare and

  • Genetic link between inflammatory bowel disease and Parkinson’s disease
    by Joanna Harvey on May 14, 2024 at 2:57 pm

    A genetic link between inflammatory bowel disease (IBD) and Parkinson’s disease (PD) has been identified by researchers at the Icahn School of Medicine, Mount Sinai. The team used advanced genomic analysis techniques to investigate the genetic overlap between IBD and PD, with their findings pointing to mutations in the LRRK2 gene as a common element

  • NICE recommends first treatment for rare heart condition
    by Joanna Harvey on May 13, 2024 at 11:50 am

    The National Institute for Health and Care Excellence (NICE) has published final draft guidance which recommends Vyndaqel®▼ (tafamidis) for the treatment of wild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM)1 to be routinely available on the NHS. The NICE final draft guidance is subject to appeal, with final guidance anticipated in June. However,

  • Europe’s decisive role in global healthcare’s future
    by Karl Hamer on May 9, 2024 at 11:40 am

    As we look ahead to 2028, a confluence of factors will position Europe to play a decisive role in shaping the future of global healthcare. From policy leadership to research and development prowess, Europe’s impact will be felt across many dimensions. Policy and regulatory harmonisation One of the key drivers will be Europe’s continued push

  • Positive results from head and neck cancer trial
    by Joanna Harvey on May 8, 2024 at 3:10 pm

    Calliditas Therapeutics have confirmed positive data from the proof-of-concept Phase 2 trial, in patients with head and neck cancer. The trial evaluated setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and neck (SCCHN). The analysis showed statistically significant improvements in progression-free survival (PFS), as

  • Immune cells discovery could lead to personalised breast cancer treatments
    by Joanna Harvey on May 7, 2024 at 2:21 pm

    The discovery of key features of immune B cells, which make them successful at targeting tumours – including when cancer has spread to a different part of the body – could lead to improved, personalised immunotherapies and treatments for advanced breast cancer. Most immunotherapies only work for a minority of patients, and researchers are urgently

  • NHS rolls out ‘life-changing’ treatment for sickle cell disease
    by Joanna Harvey on May 3, 2024 at 2:23 pm

    Thousands of patients with sickle cell disease are to be offered a new ‘life-changing’ treatment on the NHS, following the approval and roll-out of a new drug, Oxbryta®▼ (voxelotor), that could significantly improve their quality of life. Up to 4,000 people with sickle cell disease in England could benefit from the drug if recommended by

  • Prescribing pharmacists; a game-changer in the UK healthcare market
    by Kate Kelly on May 2, 2024 at 1:07 pm

    The healthcare delivery landscape in the UK is transforming with the rise of prescribing pharmacists. Pharmacists have seen an evolvement with their role in the last decade with respect to supporting patients, NHS initiatives, and creating quicker access to care. We are now seeing them play an increasingly active part in patient care, obtaining prescribing

  • ABPI respond to proposals to change the Statutory Scheme
    by Emma Cooper on May 2, 2024 at 11:35 am

    The Association of the British Pharmaceutical Industry (ABPI) has published an executive summary1 of its consultation response to the government’s proposed changes to the Statutory Scheme for branded medicines2. In its response, the ABPI acknowledged and broadly supported the government’s intention to bring the Statutory Scheme into alignment with the new Voluntary Scheme for Pricing

  • Novartis’ leukaemia treatment to be made available on the NHS
    by Joanna Harvey on May 2, 2024 at 10:49 am

    Children and young adults with a form of leukaemia that develops rapidly are set to benefit after the National Institute for Health and Care Excellence (NICE) has recommended an innovative, life-extending treatment, where the person’s own immune cells are modified to fight the cancer, be made available on the NHS. Tisagenlecleucel has been available within

  • NICE recommends a new treatment for preventing migraines
    by Joanna Harvey on April 29, 2024 at 11:08 am

    A final draft guidance published by The National Institute for Health and Care Excellence (NICE) has recommended atogepant, the first of a new type of oral treatment option for preventing both chronic and episodic migraines. This news opens the way for up to 170,000 people to choose it on the NHS in England. Also called

  • NICE recommends new Novartis treatment for brain tumours
    by Joanna Harvey on April 25, 2024 at 11:14 am

    The National Institute for Health and Care Excellence (NICE) has recommended a new targeted drug combination treatment, described as a ‘step-change in care’ for children and young people in England and Wales, with an aggressive form of brain tumour. Dabrafenib (also known as Finlee) in combination with trametinib (also known as Spexotras, both made by

  • Multiple myeloma treatment approved by the European Commission
    by Joanna Harvey on April 23, 2024 at 10:50 am

    The European Commission (EC) has approved a Type II variation for CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) for the treatment of adult patients with relapsed and refractory multiple myeloma (RRMM), who have received at least one prior therapy, including an immunomodulatory agent (IMiD) and a proteasome inhibitor (PI) and have demonstrated disease progression on the last therapy,

  • Scientists discover breakthrough to treat inflammatory diseases
    by Joanna Harvey on April 22, 2024 at 1:17 pm

    Scientists have discovered a breakthrough that could potentially lead to the development of selective HDAC inhibitors designed to treat types of inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn’s disease and other inflammatory diseases. Mount Sinai researchers found the biological mechanisms by which a family of proteins known as histone deacetylases (HDACs) activate

  • Promising new treatment strategy for aggressive form of leukaemia
    by Joanna Harvey on April 18, 2024 at 10:16 am

    A promising treatment strategy for an aggressive type of leukaemia – acute myeloid leukaemia (AML) – through targeting the enzymes that cells normally use to sense and adapt to changing oxygen levels, has been uncovered. Researchers have found that blocking oxygen-sensing enzymes can significantly halt acute myeloid leukaemia in mice and patient samples without affecting

  • Cancer cell discovery reveals two potential drug targets against skin cancer
    by Joanna Harvey on April 17, 2024 at 10:23 am

    A new cancer cell discovery into how skin cancer cells shapeshift based on their environment could offer potential new drug targets to stop skin cancer from metastasising. Scientists at The Institute of Cancer Research, London, uncovered how cells know what environment they are in and therefore which shape to choose. Working in collaboration with researchers

  • New landmark licensing agreement for Meningitis-B vaccine
    by Joanna Harvey on April 16, 2024 at 10:10 am

    In a new landmark licensing agreement towards addressing the challenge of Meningitis-B, the University of Oxford and Serum Institute of India Pvt. Ltd (SIIPL) have formalised a Licence of Technology Agreement negotiated by Oxford University Innovation, delivering lifesaving protection against Meningitis-B through the production of a chimeric protein-based vaccine. After five years of work, SIIPL

  • Idorsia’s insomnia drug accepted for use within NHS Scotland
    by Joanna Harvey on April 10, 2024 at 9:31 am

    The Scottish Medicines Consortium (SMC) has accepted Idorsia UK Ltd’s drug, QUVIVIQ™▼ (daridorexant), for restricted use within NHS Scotland. The drug will be used for the treatment of adult patients with insomnia characterised by symptoms present for at least three months and considerable impact on daytime functioning, who have failed cognitive behavioural therapy for insomnia

  • Dispenser Development Program
    by Greg Bull on February 29, 2024 at 2:37 pm

    Are you a qualified dispenser who wants to develop their skills and knowledge further to benefit their practice more? Are you a dispensary manager who needs more confidence and knowledge to manage the dispensary team and finances more effectively? Have you got a dispensary where the manager is nearing retirement or needs extra help form

  • FAQ – Testing Strips
    by Greg Bull on October 3, 2023 at 6:41 pm

    Question: I have a question about monitoring and the use of testing strips.  Not sure whether this is a good subject for one of your hints and tips emails? When a patient home monitors they will be prescribed strips and therefore an FP10 claimable. If using in the surgery can we prescribe?  I think they

  • FAQ – Another PA Item Query
    by Greg Bull on October 3, 2023 at 6:39 pm

    Question: Thank you for the recent webinar with regards to PA VAT and Profitable Dispensing. Can you point me in the right direction to find the list of HMRC PA Items? As this has got me slightly worried on how I divide by monthly drug statements between PA Items and Dispensing items.  At the moment

  • Clara – A Digital CD Register for Your Dispensary
    by Greg Bull on October 3, 2023 at 4:36 pm

    Welcome to Clara Electronic Controlled Drug Register ( eCDR ) ( 30 day Free Trial )- as recommended by Dispensing Doctors Experts. Join the many dispensing doctors surgeries up and down the country ditching paper to use Clara eCDR What customers say: “ We have saved on average 2 hours a week using Clara Electronic CD

  • Croner – Our Trusted HR Provider
    by Greg Bull on October 3, 2023 at 4:19 pm

    For over 80 years, our award-winning team have delivered outsourced HR, employment law and health & safety services to UK businesses. We support your business compliance at all levels. Our expert UK-based advisors provide a service that is designed around the challenges or needs of your organisation. Our point of difference is that we’re not an off-the-shelf provider. We tailor our approach

  • FREE Dispensing Roadshows Spring 2024
    by Greg Bull on August 22, 2023 at 3:00 pm

    A Free Half-Day Dispensing Roadshow with the Experts Greg Bull and Alastair Carmichael of Dispensing Doctor Experts, 35+ years’ experience VENUES to be confirmed but please register for interest NOW as places are limited for each event. All events 830am registration, all events end at 2pm after a working lunch email contact@dispensingdoctorexperts.co.uk to register for

  • TITAN Gets Approval For Dispensing Doctors
    by Greg Bull on August 4, 2023 at 10:33 am

    Electronic prescription dispensing is set to penetrate the most remote and rural corners of England after a ground-breaking piece of software was accredited by the NHS. Titan PMR has become the first viable software to be given full release authority by the NHS to provide electronic prescription services (EPS) to dispensing doctors. As a dispensing

  • Contrelle Now Available on Prescription
    by Greg Bull on June 19, 2023 at 10:23 am

    Contrelle Activgard is now listed in Part IX of the Drug Tariff and can now be prescribed by general practitioners. 1/3 of women are reported to suffer from stress urinary incontinence, impacting both their quantity and quality of exercise and mental health. Contrelle is a disposable bladder support, which offers a simple, self-administered approach to

  • Your PCSE Statement Explained
    by Greg Bull on March 13, 2023 at 2:59 pm

    Having taught the PCSE Statement webinar a few times now, and having taught it in person one to one, online and face to face, it strikes me that this is an area which is still often misunderstood. If you would like to book an online session where we go through YOUR PCSE statement, section by

  • NEW One-to-One Training
    by Greg Bull on December 1, 2022 at 4:37 pm

    For January and February we are offering one hour online training sessions for dispensary staff covering Management Accounts, PCSE Statement Explained, Principles of Dispensary Management, Dispensary Design for Profit and more. A one hour online session can be booked for as little as £200 + VAT For in house training on site at your practice

  • Influencing Skills
    by Pharmaceutical Services Negotiating Committee on June 29, 2018 at 12:00 pm

    In this PSNC podcast we explore how to learn and use influencing skills to promote community pharmacy in the changing commissioning environment. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • Change management
    by Pharmaceutical Services Negotiating Committee on June 1, 2017 at 11:09 am

    As the NHS continues to change, LPCs need to be able to adapt to the changes and support contractors in changing times. This podcast discusses how to manage change both within and outside the LPC. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide). [...]

  • How to be a mentor
    by Pharmaceutical Services Negotiating Committee on May 31, 2017 at 10:47 am

    Learn more about mentoring, an adaptable skill that can be used within community pharmacy and beyond. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • Negotiation skills
    by Pharmaceutical Services Negotiating Committee on November 7, 2016 at 4:53 pm

    Led by negotiation skills trainer Phil Parry this PSNC MyCoach podcast provides tips on how to avoid failure and improve success. Supported by Pfizer Limited. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • Facilitation skills
    by Pharmaceutical Services Negotiating Committee on November 4, 2016 at 2:42 pm

    Facilitating an LPC planning meeting  or contractor meeting? This  short PSNC MyCoach podcast will sharpen skills and boost your confidence. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • Chairing meetings
    by Pharmaceutical Services Negotiating Committee on November 3, 2016 at 12:52 pm

    For new LPC chairs or experienced chairs looking for tips and ideas – a PSNC MyCoach podcast on chairing meetings, with training consultant Phil Parry. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

  • LPCs and market entry applications
    by Pharmaceutical Services Negotiating Committee on July 6, 2016 at 10:01 am

    In this PSNC podcast we discuss why LPCs are consulted on market entry applications; what if the applicant is not an existing contractor in the LPC area; what LPCs should and shouldn’t take into account when considering an application; what about distance selling applications; governance and conflicts of interests? Listen to more of our podcasts [...]

  • Leadership
    by Pharmaceutical Services Negotiating Committee on July 4, 2016 at 12:18 pm

    With Rachel Harrison who leads PSNC’s Leadership Academy. Rachel discusses the qualities she has seen in some of the LPC members and officers that single them out as potential leaders. The qualities LPC leaders possess; what make people follow leaders? Key aspects of change management and coaching; the different styles of leadership? What sort of [...]